Teladoc Health, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 8 | -$0.49 | -$0.44 | -$0.46 |
Q2 2024 | 8 | -$0.37 | -$0.33 | -$0.34 |
Q3 2024 | 3 | -$0.29 | -$0.26 | -$0.28 |
Q4 2024 | 5 | -$0.31 | -$0.04 | -$0.23 |
Q1 2025 | 5 | -$0.40 | -$0.19 | -$0.31 |
Q2 2025 | 4 | -$0.25 | -$0.22 | -$0.23 |
Q3 2025 | 4 | -$0.23 | -$0.21 | -$0.22 |
Q4 2025 | 4 | -$0.16 | -$0.14 | -$0.15 |
Q1 2026 | 3 | -$0.37 | -$0.33 | -$0.35 |
Q2 2026 | 3 | -$0.28 | -$0.25 | -$0.27 |
Q3 2026 | 3 | -$0.27 | -$0.24 | -$0.25 |
Q4 2026 | 3 | -$0.22 | -$0.19 | -$0.20 |
Q1 2027 | 3 | -$0.29 | -$0.26 | -$0.27 |
Q2 2027 | 3 | -$0.21 | -$0.19 | -$0.20 |
Q3 2027 | 3 | -$0.11 | -$0.10 | -$0.10 |
Q4 2027 | 3 | $0.17 | $0.19 | $0.18 |
Teladoc Health, Inc. Earnings Date And Information
Teladoc Health, Inc. last posted its earnings results on Wednesday, October 30th, 2024. The company reported $-0.19 earnings per share for the quarter, topping analysts' consensus estimates of $-0.29 by $0.1. The company had revenue of 640.51 M for the quarter and had revenue of 2.60 B for the year. Teladoc Health, Inc. has generated $-1 earnings per share over the last year ($-1.34 diluted earnings per share) and currently has a price-to-earnings ratio of -1.8. Teladoc Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based on prior year's report dates.
Teladoc Health, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/31/2024 | Q3 2024 | -$0.20 | $631.18 M | $640.51 M | ||
08/01/2024 | Q2 2024 | -$4.92 | $649.16 M | $642.44 M | ||
04/26/2024 | Q1 2024 | -$0.49 | $646.13 M | |||
02/23/2024 | Q4 2023 | -$0.17 | $660.53 M | |||
10/27/2023 | Q3 2023 | -$0.35 | $663.54 M | $660.24 M | ||
07/28/2023 | Q2 2023 | -$0.40 | $649.18 M | $652.41 M | ||
05/02/2023 | Q1 2023 | -$0.42 | $629.24 M | |||
03/01/2023 | Q4 2022 | -$23.49 | $637.71 M | |||
11/02/2022 | Q3 2022 | -$0.45 | $608.89 M | $611.40 M | ||
08/03/2022 | Q2 2022 | -$19.22 | $586.74 M | $592.38 M | ||
05/02/2022 | Q1 2022 | -$41.58 | $565.35 M | |||
02/28/2022 | Q4 2021 | -$0.07 | $554.24 M | |||
11/01/2021 | Q3 2021 | -$0.53 | $516.63 M | $521.66 M | ||
08/02/2021 | Q2 2021 | -$0.86 | $500.60 M | $503.14 M | ||
05/03/2021 | Q1 2021 | -$1.31 | $453.68 M | |||
03/01/2021 | Q4 2020 | -$3.07 | $383.32 M | |||
11/06/2020 | Q3 2020 | -$0.43 | $282.18 M | $288.81 M | ||
07/29/2020 | Q2 2020 | -$0.23 | -$0.34 | -0.11 | $220.67 M | $241.03 M |
04/29/2020 | Q1 2020 | -$0.35 | -$0.40 | -0.05 | $180.80 M | |
02/26/2020 | Q4 2019 | -$0.33 | -$0.26 | 0.07 | $156.49 M |
Teladoc Health, Inc. Earnings: Frequently Asked Questions
-
When is Teladoc Health, Inc.'s earnings date?
Teladoc Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates.
-
Did Teladoc Health, Inc. beat their earnings estimates last quarter?
In the previous quarter, Teladoc Health, Inc. (:TDOC) reported $-0.19 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.29 by $0.1.
-
How can I listen to Teladoc Health, Inc.'s earnings conference call?
The conference call for Teladoc Health, Inc.'s latest earnings report can be listened to online.
-
How can I read Teladoc Health, Inc.'s conference call transcript?
The conference call transcript for Teladoc Health, Inc.'s latest earnings report can be read online.
-
How much revenue does Teladoc Health, Inc. generate each year?
Teladoc Health, Inc. (:TDOC) has a recorded annual revenue of $2.60 B.
-
How much profit does Teladoc Health, Inc. generate each year?
Teladoc Health, Inc. (:TDOC) has a recorded net income of $2.60 B. Teladoc Health, Inc. has generated $-1.36 earnings per share over the last four quarters.
-
What is Teladoc Health, Inc.'s price-to-earnings ratio?
Teladoc Health, Inc. (:TDOC) has a price-to-earnings ratio of -1.8 and price/earnings-to-growth ratio is -0.67.